Geneva, Sept. 21 -- International Clinical Trials Registry received information related to the study (ChiCTR2600131793) titled 'Ustekinumab Combined with Upadacitinib Promotes Mucosal Healing in Patients with Active Crohn's Disease Who Failed Anti-TNF-a Therapy' on Sept. 7.
Study Type: Observational study
Study Design:
Sequential
Primary Sponsor: Shanghai Tenth People's Hospital
Condition:
Crohn's disease
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2025-09-15
Target Sample Size: Crohn's disease treatment observation group:110;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/showproj.html?proj=296203
Published by HT Digital Content Services with permission from Heal...